Mastocytic enterocolitis: Increased mucosal mast cells in chronic intractable diarrhea

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 3, 2006, Pages 362-367

  Jakate, Shriram ^a   Demeo, Mark ^a   John, Rohan ^a   Tobin, Mary ^a   Keshavarzian, Ali ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; TRYPTASE;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CELL COUNT; CELL FUNCTION; CHRONIC DIARRHEA; CLINICAL ARTICLE; COLLAGENOUS COLITIS; COLON BIOPSY; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; DUODENUM BIOPSY; ENTERITIS; ENTEROCOLITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC COLITIS; MALE; MAST CELL; MASTOCYTIC ENTEROCOLITIS; MASTOCYTOSIS; MEDIATOR RELEASE; NOMENCLATURE; STAINING; SYMPTOMATOLOGY;

ADULT; AGED; CELL COUNT; CETIRIZINE; CHRONIC DISEASE; COLON; DIARRHEA; DRUG THERAPY, COMBINATION; DUODENUM; ENTEROCOLITIS; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INTESTINAL MUCOSA; MALE; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; RANITIDINE; SERINE ENDOPEPTIDASES; TREATMENT OUTCOME; TRYPTASES;

EID: 33644967312     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1464-1486.
2. American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1461-1463.
3. Schiller LR. Chronic diarrhea. Gastroenterology. 2004;127:287-293.
4. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology. 2002; 122:1701-1714.
5. Stevens RL, Austen KF. Recent advances in the cellular and molecular biology of mast cells. Immunol Today. 1989;10:381-386.
6. +, and expresses aminopeptidase N (CD13). Blood. 1999;94:2333-2342.
7. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA. 1986;83:4464-4468.
8. Friend DS, Ghildyal N, Austen KF, Gurish MF, Matsumoto R, Stevens RL. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J Cell Biol. 1996;135:279-290.
9. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol. 2004;114:21-27.
10. Santos J, Saperas E, Nogueiras C, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology. 1998;114:640-648.
11. Wood JD. Enteric neuroimmunophysiology and pathophysiology. Gastroenterology. 2004;127:635-657.
12. Castells MC. Mastocytosis: classification, diagnosis, and clinical presentation. Allergy Asthma Proc. 2004;25:33-36.
13. Miner PB Jr. The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis. J Invest Dermatol. 1991;96:40S-44S.
14. Cherner JA, Jensen RT, Dubois A, O'Dorisio TM, Cardner JD, Metcalfe DD. Gastrointestinal dysfunction in systemic mastocytosis. Gastroenterology. 1988;95: 657-667.
15. Libel R, Biddle WL, Miner PB Jr. Evaluation of anorectal physiology in patients with increased mast cells. Dig Dis Sci. 1993;38:877-881.
16. de Jonge WJ, The FO, van der Coelen D, et al. Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology. 2004;127:535-545.
17. Stoyanova II, Gulubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem. 2002;104:185-192.
18. He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol. 2004;10:309-318.
19. Minocha A, Thomas C, Omar R. Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice. Dig Dis Sci. 1995;40;1757-1762.
20. Bischoff SC, Wedemeyer J, Herrmann A, et al. Histopathology. 1996;28: 1-13.
21. Raithel M, Winterkamp S, Pacurar A, Ulrich P, Hochberger J, Hahn EG. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand J Gastroenterol. 2001;36:174-179.
22. Crowe SE, Luthra GK, Perdue MH. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Gut. 1997; 41:785-792.
23. Schwab D, Raithel M, Hahn EG. Evidence for mast cell activation in collagenous colitis. Inflamm Res. 1998;47(suppl 1):S64-S65.
24. Nishida Y, Murase K, Isomoto H, et al. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology. 2002;49:678-682.
25. Wingren U, Hallert C, Norrby K, Enerback L. Histamine and mucosal mast cells in gluten enteropathy. Agents Actions. 1986;18:266-268.
26. Horvath K, Simon K, Horn G, Bodanszky H. Mast cell degranulation after a single dose of gliandin in the jejunum of patients with celiac disease. Acta Paediatr Hung. 1986;27:311-316.
27. Suranyi Y, Freier S, Faber J, Dollberg L. Intestinal mast cells in different stages of celiac disease. Isr J Med Sci. 1986;22:370-375.
28. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108-2131.
29. O'Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil. 2000;12:449-457.
30. Weston AP, Biddle WL, Bhatia PS, Miner PB. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci. 1993;38:1590-1595.
31. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122:1778-1783.
32. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia. 2004;59:695-703.